US 11,672,803 J1 (301st)
	Use of inhibitors of brutons tyrosine kinase (BTK)
Joseph J. Buggy
Assigned to PHARMACYCLICS LLC
Trial No. PGR2024-00009, Nov. 1, 2023
Post-Grant Review Certificate for Patent 11,672,803, issued Jun. 13, 2023, Appl. No. 16/926,280, Jul. 10, 2020
Post-Grant Review Certificate issued Oct. 21, 2025